Lenz Therapeutics, Inc. · NASDAQ:LENZ
FMR LLC reported a 11.80% stake in Lenz Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 5, 2026
FMR LLC reported a 11.80% stake in Lenz Therapeutics, Inc., 3,702,718 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).
- Stake
- 11.80%
- Shares
- 3,702,718
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 11.80% | 3,702,718 |
| Abigail P. Johnson | 11.80% | 3,702,718 |
Source
Related
- Lenz Therapeutics, Inc.
- FMR LLC
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · FMR LLC · Nov 7, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Feb 17, 2026